ADAR1 Capital Management, LLC

InMed Pharmaceuticals Inc. ยท 10% Owner

ADAR1 Capital Management, LLC is listed in public filings as 10 percent owner. This ADAR1 Capital Management, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include InMed Pharmaceuticals Inc. (INM), Rallybio Corporation (RLYB), Keros Therapeutics, Inc. (KROS), and Pieris Pharmaceuticals, Inc. (PIRS). Investors use ADAR1 Capital Management, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
InMed Pharmaceuticals Inc.INM$936k600k sharesBuyMay 19, 2026$312.1K200k shares$1.56--
InMed Pharmaceuticals Inc.INM$1.2M800k sharesBuyMay 19, 2026$299.8K200k shares$1.50--
Rallybio CorporationRLYB$13M926.4k sharesBuyMay 19, 2026$2.8K200 shares$13.80--
Rallybio CorporationRLYB$13M926.2k sharesBuyMay 19, 2026$139.8K10k shares$13.98--
InMed Pharmaceuticals Inc.INM$640k400k sharesBuyMay 19, 2026$109.7K68.6k shares$1.60--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rallybio CorporationRLYB$13M916.2k sharesBuyMay 18, 2026$84.0K6k shares$13.98--
Rallybio CorporationRLYB$13M910.1k sharesBuyMay 15, 2026$2.8K200 shares$13.95--
Rallybio CorporationRLYB$13M909.9k sharesBuyMay 15, 2026$1.4K100 shares$13.80--
Rallybio CorporationRLYB$13M909.8k sharesBuyMay 13, 2026$1.1M75.2k shares$14.00--
Rallybio CorporationRLYB$12M834.7k sharesBuyMay 13, 2026$56.3K4.1k shares$13.80--
Rallybio CorporationRLYB$11M830.6k sharesBuyMay 12, 2026$11.1K800 shares$13.83--
Rallybio CorporationRLYB$11M809.9k sharesBuyMay 11, 2026$350.0K25k shares$14.00--
Rallybio CorporationRLYB$12M829.8k sharesBuyMay 11, 2026$278.6K19.9k shares$14.00--
Rallybio CorporationRLYB$11M784.9k sharesBuyMay 11, 2026$71.4K5.1k shares$14.00--
Rallybio CorporationRLYB$11M779.8k sharesBuyMay 5, 2026$491.3K35.1k shares$14.00--
Rallybio CorporationRLYB$10M744.7k sharesBuyMay 4, 2026$1.6M116.9k shares$13.97--
Rallybio CorporationRLYB$8.7M627.8k sharesBuyMay 4, 2026$54.2K3.9k shares$13.90--
Keros Therapeutics, Inc.KROS$0743.4k sharesSellOct 15, 2025$13.2M743.4k shares$17.75--
Keros Therapeutics, Inc.KROS$02 sharesOtherJun 20, 2025$1402 shares$70.00--
Keros Therapeutics, Inc.KROS$01 sharesOtherJun 20, 2025$601 shares$60.00--
Keros Therapeutics, Inc.KROS$307M4.4M sharesOtherJun 20, 2025$98.0K1.4k shares$70.00--
Keros Therapeutics, Inc.KROS$52M743.4k sharesOtherJun 20, 2025$14.0K200 shares$70.00--
Keros Therapeutics, Inc.KROS$264M4.4M sharesOtherJun 20, 2025$6.0K100 shares$60.00--
Keros Therapeutics, Inc.KROS$0178 sharesOtherMay 16, 2025$1.8K178 shares$10.00--
Keros Therapeutics, Inc.KROS$45M4.3M sharesBuyApr 9, 2025$5.2M500k shares$10.33--
Keros Therapeutics, Inc.KROS$38M3.8M sharesBuyApr 9, 2025$3.2M325k shares$9.86--
Keros Therapeutics, Inc.KROS$45M4.4M sharesBuyApr 9, 2025$767.9K74.3k shares$10.33--
Keros Therapeutics, Inc.KROS--50k sharesOtherApr 9, 2025Disclosure amount unavailable74.3k shares----
Keros Therapeutics, Inc.KROS--124.3k sharesOtherApr 9, 2025Disclosure amount unavailable500k shares----
Keros Therapeutics, Inc.KROS--624.3k sharesOtherApr 9, 2025Disclosure amount unavailable325k shares----
Keros Therapeutics, Inc.KROS$33M3.5M sharesBuyApr 9, 2025$174.4K18.6k shares$9.40--
Keros Therapeutics, Inc.KROS$7.0M743.6k sharesBuyApr 9, 2025$153.8K16.4k shares$9.40--
Pieris Pharmaceuticals, Inc.PIRS$2.1M129.6k sharesBuyAug 12, 2024$35.6K2.2k shares$15.88--
Pieris Pharmaceuticals, Inc.PIRS$239k15.1k sharesBuyAug 12, 2024$12.0K757 shares$15.88--
Pieris Pharmaceuticals, Inc.PIRS$1.9M127.3k sharesBuyAug 9, 2024$44.7K3k shares$14.89--